C.M. Bidwell & Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-644
| Closed | -$80K | – | 474 |
|
|
2025
Q1 | $80K | Sell |
644
-15
| -2% | -$1.86K | 0.05% | 175 |
|
|
2024
Q4 | $81.2K | Sell |
659
-3
| -0.5% | -$369 | 0.05% | 187 |
|
|
2024
Q3 | $73.8K | Buy |
+662
| New | +$73.8K | 0.05% | 202 |
|
|
2023
Q4 | – | Sell |
-1,093
| Closed | -$141K | – | 534 |
|
|
2023
Q3 | $141K | Buy |
+1,093
| New | +$141K | 0.11% | 163 |
|
|
2023
Q2 | – | Sell |
-689
| Closed | -$101K | – | 556 |
|
|
2023
Q1 | $101K | Sell |
689
-52
| -7% | -$7.61K | 0.08% | 231 |
|
|
2022
Q4 | $118K | Buy |
741
+451
| +156% | +$71.8K | 0.09% | 197 |
|
|
2022
Q3 | $39K | Hold |
290
| – | – | 0.03% | 290 |
|
|
2022
Q2 | $45K | Hold |
290
| – | – | 0.04% | 284 |
|
|
2022
Q1 | $45K | Buy |
+290
| New | +$45K | 0.03% | 293 |
|
|
2021
Q3 | – | Sell |
-1,615
| Closed | -$287K | – | 588 |
|
|
2021
Q2 | $287K | Buy |
1,615
+155
| +11% | +$27.5K | 0.19% | 95 |
|
|
2021
Q1 | $240K | Sell |
1,460
-200
| -12% | -$32.9K | 0.18% | 100 |
|
|
2020
Q4 | $274K | Sell |
1,660
-70
| -4% | -$11.6K | 0.22% | 67 |
|
|
2020
Q3 | $247K | Buy |
+1,730
| New | +$247K | 0.23% | 79 |
|
|
2019
Q2 | – | Sell |
-1,815
| Closed | -$259K | – | 423 |
|
|
2019
Q1 | $259K | Buy |
+1,815
| New | +$259K | 0.26% | 106 |
|
|
2014
Q2 | – | Sell |
-1,415
| Closed | -$196K | – | 264 |
|
|
2014
Q1 | $196K | Sell |
1,415
-365
| -21% | -$50.6K | 0.05% | 144 |
|
|
2013
Q4 | $225K | Buy |
+1,780
| New | +$225K | 0.06% | 149 |
|